The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Polymer Therapeutics: Concepts and Applications
Abstract
Polymer therapeutics encompass polymer–protein conjugates, drug–polymer conjugates, and supramolecular drug‐delivery systems. Numerous polymer–protein conjugates with improved stability and pharmacokinetic properties have been developed, for example, by anchoring enzymes or biologically relevant proteins to polyethylene glycol components (PEGylation). Several polymer–protein conjugates have received market approval, for example the PEGylated form of adenosine deaminase. Coupling low‐molecular‐weight anticancer drugs to high‐molecular‐weight polymers through a cleavable linker is an effective method for improving the therapeutic index of clinically established agents, and the first candidates have been evaluated in clinical trials, including, N‐(2‐hydroxypropyl)methacrylamide conjugates of doxorubicin, camptothecin, paclitaxel, and platinum(II) complexes. Another class of polymer therapeutics are drug‐delivery systems based on well‐defined multivalent and dendritic polymers. These include polyanionic polymers for the inhibition of virus attachment, polycationic complexes with DNA or RNA (polyplexes), and dendritic core–shell architectures for the encapsulation of drugs. In this Review an overview of polymer therapeutics is presented with a focus on concepts and examples that characterize the salient features of the drug‐delivery systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Crystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Mammen, M., Choi, S.-K., & Whitesides, G. M. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981102)37:20<2754::aid-anie2754>3.0.co;2-3 · Cited by 4,110
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Tomalia, D. A., Naylor, A. M., & Goddard, W. A. (1990) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199001381 · Cited by 3,211
Cited by
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Kratz, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.010 · Cited by 2,151
Self-citationFluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
Chen, X., Pradhan, T., Wang, F., Kim, J. S., & Yoon, J. (2012) · Chemical Reviews · doi:10.1021/cr200201z · Cited by 1,984
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Biodegradable composites based on lignocellulosic fibers—An overview
Satyanarayana, K. G., Arizaga, G. G. C., & Wypych, F. (2009) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2008.12.002 · Cited by 1,421
Bioapplications of RAFT Polymerization
Boyer, C., Bulmus, V., Davis, T. P., Ladmiral, V., Liu, J., & Perrier, S. (2009) · Chemical Reviews · doi:10.1021/cr9001403 · Cited by 1,015
Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery
Vivero‐Escoto, J. L., Slowing, I. I., Trewyn, B. G., & Lin, V. S. ‐. (2010) · Small · doi:10.1002/smll.200901789 · Cited by 998
Nanomaterials: Applications in Cancer Imaging and Therapy
Barreto, J. A., O’Malley, W., Kubeil, M., Graham, B., Stephan, H., & Spiccia, L. (2011) · Advanced Materials · doi:10.1002/adma.201100140 · Cited by 907
Targeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Dendrimers as Carriers for Delivery of Chemotherapeutic Agents
Medina, S. H., & El-Sayed, M. E. H. (2009) · Chemical Reviews · doi:10.1021/cr900174j · Cited by 669
Greco, F., & Vicent, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.006 · Cited by 652
Dendritic Polyglycerols for Biomedical Applications
Calderón, M., Quadir, M. A., Sharma, S. K., & Haag, R. (2010) · Advanced Materials · doi:10.1002/adma.200902144 · Cited by 629
Self-citationLutz, J.-F., & Zarafshani, Z. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.02.004 · Cited by 549
Yuan, Y., Mao, C., Du, X., Du, J., Wang, F., & Wang, J. (2012) · Advanced Materials · doi:10.1002/adma.201202296 · Cited by 529
Kim, J., Lee, J. E., Lee, S. H., Yu, J. H., Lee, J. H., Park, T. G., & Hyeon, T. (2008) · Advanced Materials · doi:10.1002/adma.200701726 · Cited by 494
Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery
Gullotti, E., & Yeo, Y. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900090z · Cited by 473
Li, Y., Zhu, L., Liu, Z., Cheng, R., Meng, F., Cui, J., Ji, S., & Zhong, Z. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200904260 · Cited by 451
Alternatives to Gadolinium-Based Metal Chelates for Magnetic Resonance Imaging
Viswanathan, S., Kovacs, Z., Green, K. N., Ratnakar, S. J., & Sherry, A. D. (2010) · Chemical Reviews · doi:10.1021/cr900284a · Cited by 439
Multifunctional dendritic polymers in nanomedicine: opportunities and challenges
Khandare, J., Calderón, M., Dagia, N. M., & Haag, R. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15242d · Cited by 418
Self-citationWell-Defined Protein−Polymer Conjugates via in Situ RAFT Polymerization
Boyer, C., Bulmus, V., Liu, J., Davis, T. P., Stenzel, M. H., & Barner-Kowollik, C. (2007) · Journal of the American Chemical Society · doi:10.1021/ja070956a · Cited by 411
Pan, Y.-J., Chen, Y.-Y., Wang, D.-R., Wei, C., Guo, J., Lu, D.-R., Chu, C.-C., & Wang, C.-C. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.062 · Cited by 379
Nanovehicular Intracellular Delivery Systems
Prokop, A., & Davidson, J. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21270 · Cited by 363
Layer-by-Layer Nanoparticles with a pH-Sheddable Layer for in Vivo Targeting of Tumor Hypoxia
Poon, Z., Chang, D., Zhao, X., & Hammond, P. T. (2011) · ACS Nano · doi:10.1021/nn200876f · Cited by 343
Mignani, S., El Kazzouli, S., Bousmina, M., & Majoral, J.-P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.01.001 · Cited by 335
Miktoarm star polymers: advances in synthesis, self-assembly, and applications
Khanna, K., Varshney, S., & Kakkar, A. (2010) · Polymer Chemistry · doi:10.1039/c0py00082e · Cited by 329
Dong, K., Liu, Z., Li, Z., Ren, J., & Qu, X. (2013) · Advanced Materials · doi:10.1002/adma.201301232 · Cited by 325
Design and Creativity in Synthesis of Multivalent Neoglycoconjugates
Chabre, Y. M., & Roy, R. (2010) · Advances in Carbohydrate Chemistry and Biochemistry · doi:10.1016/s0065-2318(10)63006-5 · Cited by 319
Building nanostructures using RAFT polymerization
Boyer, C., Stenzel, M. H., & Davis, T. P. (2011) · Journal of Polymer Science Part A: Polymer Chemistry · doi:10.1002/pola.24482 · Cited by 314
Administration, distribution, metabolism and elimination of polymer therapeutics
Markovsky, E., Baabur-Cohen, H., Eldar-Boock, A., Omer, L., Tiram, G., Ferber, S., Ofek, P., Polyak, D., Scomparin, A., & Satchi-Fainaro, R. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.021 · Cited by 313
Percec, V., Leowanawat, P., Sun, H.-J., Kulikov, O., Nusbaum, C. D., Tran, T. M., Bertin, A., Wilson, D. A., Peterca, M., Zhang, S., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja403323y · Cited by 310
Prodrug-based intracellular delivery of anticancer agents
Bildstein, L., Dubernet, C., & Couvreur, P. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.005 · Cited by 310
Anticancer Polymeric Nanomedicines
Tong, R., & Cheng, J. (2007) · Polymer Reviews · doi:10.1080/15583720701455079 · Cited by 310
Antibody–Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review
Lambert, J. M., & Morris, C. Q. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0519-6 · Cited by 304
Gaspar, R., & Duncan, R. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.003 · Cited by 304
Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications
Banerjee, S. S., Aher, N., Patil, R., & Khandare, J. (2012) · Journal of Drug Delivery · doi:10.1155/2012/103973 · Cited by 282
Antitumour immunity regulated by aberrant ERBB family signalling
Kumagai, S., Koyama, S., & Nishikawa, H. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00322-0 · Cited by 278
Kolin, D. L., & Wiseman, P. W. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-9000-5 · Cited by 277
In vitro biological evaluation of high molecular weight hyperbranched polyglycerols
Kainthan, R. K., Hester, S. R., Levin, E., Devine, D. V., & Brooks, D. E. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.07.011 · Cited by 273
Engineering of amphiphilic block copolymers for polymeric micellar drug and gene delivery
Xiong, X.-B., Falamarzian, A., Garg, S. M., & Lavasanifar, A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.04.028 · Cited by 268
Conjugated Polymer Nanoparticles for Drug Delivery and Imaging
Feng, X., Lv, F., Liu, L., Tang, H., Xing, C., Yang, Q., & Wang, S. (2010) · ACS Applied Materials & Interfaces · doi:10.1021/am100435k · Cited by 256
Synthesis, biodistribution and excretion of radiolabeled poly(2-alkyl-2-oxazoline)s
Gaertner, F. C., Luxenhofer, R., Blechert, B., Jordan, R., & Essler, M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.015 · Cited by 255
Physicochemical characterization of drug nanocarriers
Berbel Manaia, E., Paiva Abuçafy, M., Chiari-Andréo, B. G., Lallo Silva, B., Oshiro-Júnior, J. A., & Chiavacci, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s133832 · Cited by 207
Bauer, K. N., Tee, H. T., Velencoso, M. M., & Wurm, F. R. (2017) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2017.05.004 · Cited by 189
Gu, Y., Zhong, Y., Meng, F., Cheng, R., Deng, C., & Zhong, Z. (2013) · Biomacromolecules · doi:10.1021/bm400615n · Cited by 187
Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing Immunity
Bartel, M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00204 · Cited by 108
Costache, A. D., Sheihet, L., Zaveri, K., Knight, D. D., & Kohn, J. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900114w · Cited by 79
Functionalized carbon nanotubes for anticancer drug delivery
Lay, C. L., Liu, J., & Liu, Y. (2011) · Expert Review of Medical Devices · doi:10.1586/erd.11.34 · Cited by 71
Li, L., Wang, J., Kong, H., Zeng, Y., & Liu, G. (2018) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2018.1528850 · Cited by 71
Strategies to circumvent humoral immunity to adeno-associated viral vectors
Tse, L. V., Moller-Tank, S., & Asokan, A. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1035645 · Cited by 61
Shell cross-linked polymeric micelles as camptothecin nanocarriers for anti-HCV therapy
Jiménez‐Pardo, I., González‐Pastor, R., Lancelot, A., Claveria‐Gimeno, R., Velázquez‐Campoy, A., Abian, O., Ros, M. B., & Sierra, T. (2015) · Macromolecular Bioscience · doi:10.1002/mabi.201500094 · Cited by 28
Nanocarrier-based targeted pulmonary delivery: novel approaches for effective lung cancer treatment
Shah, M. R., Imran, M., & Ullah, S. (2019) · Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy · doi:10.1016/b978-0-12-816773-1.00006-7 · Cited by 5
Metadata
- Authors
- Haag, R., & Kratz, F.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2006-02-06
- Volume
- 45
- Issue
- 8
- Pages
- 1198-1215
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2145786098
- Cited by
- 1,115
- References
- 138
- FWCI
- 36.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.